Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 87 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 1721

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with a lytic lesion in the distal femur extending to the subchondral bone. Biopsy confirms a giant cell tumor of bone. She is treated with denosumab to downstage the tumor prior to curettage. What is the primary mechanism of action of denosumab in the treatment of this lesion?

. Direct induction of apoptosis in neoplastic stromal cells
. Inhibition of the RANKL-RANK interaction, decreasing osteoclast-like giant cell formation
. Activation of osteoprotegerin (OPG) secretion
. Inhibition of vascular endothelial growth factor (VEGF)
. Direct alkylation of DNA in rapidly dividing cells

Correct Answer & Explanation

. Inhibition of the RANKL-RANK interaction, decreasing osteoclast-like giant cell formation

Explanation

Giant cell tumors of bone consist of neoplastic mononuclear stromal cells that overexpress RANKL. This RANKL recruits and stimulates the formation of reactive osteoclast-like giant cells, which cause bone destruction. Denosumab is a monoclonal antibody that binds directly to RANKL, preventing its interaction with RANK on the osteoclast precursors, thereby halting osteolysis and allowing bone to ossify.

Question 1722

Topic: Biology, Genetics & Bone Healing

A 15-year-old boy presents with knee pain. Radiographs reveal a well-circumscribed, eccentrically located lytic lesion in the proximal tibial epiphysis with a thin sclerotic rim. Which of the following histological findings is most characteristic of this lesion?

. Mononuclear cells with scattered multinucleated giant cells and a 'chicken wire' pattern of calcification
. Spindle cells arranged in a 'herringbone' pattern
. Small blue cells forming Homer-Wright rosettes
. Woven bone trabeculae rimmed by prominent osteoblasts
. Anaplastic cells producing delicate lace-like osteoid

Correct Answer & Explanation

. Mononuclear cells with scattered multinucleated giant cells and a 'chicken wire' pattern of calcification

Explanation

The patient's presentation (epiphyseal lesion in a skeletally immature individual) points to a chondroblastoma. Histologically, it is characterized by sheets of mononuclear cells (chondroblasts), scattered osteoclast-like giant cells, and fine, pericellular 'chicken wire' calcifications. Herringbone pattern denotes fibrosarcoma. Prominent osteoblasts rimming woven bone describes an osteoblastoma. Lace-like osteoid is diagnostic of osteosarcoma.

Question 1723

Topic: Biology, Genetics & Bone Healing

A 28-year-old woman presents with persistent, aching knee pain. Radiographs reveal an eccentric, lytic epiphyseal-metaphyseal lesion of the distal femur. Biopsy reveals uniform mononuclear cells interspersed with numerous multinucleated giant cells. Which of the following describes the mechanism of action of the targeted medical therapy most commonly used for this condition?

. Inhibition of vascular endothelial growth factor (VEGF)
. Monoclonal antibody against receptor activator of nuclear factor kappa-B ligand (RANKL)
. Tyrosine kinase inhibition of c-KIT
. Selective estrogen receptor modulation
. Inhibition of matrix metalloproteinases

Correct Answer & Explanation

. Monoclonal antibody against receptor activator of nuclear factor kappa-B ligand (RANKL)

Explanation

Giant cell tumor (GCT) of bone is a locally aggressive benign tumor. The neoplastic mononuclear cells express RANKL, which recruits and activates osteoclast-like multinucleated giant cells, leading to bone destruction. Denosumab, a monoclonal antibody against RANKL, is utilized in advanced, recurrent, or unresectable GCTs to inhibit giant cell formation and function, resulting in tumor consolidation and ossification.

Question 1724

Topic: Biology, Genetics & Bone Healing
A 65-year-old man presents with diffuse bone pain and fatigue. Laboratory investigations reveal normocytic anemia, hypercalcemia, and an elevated serum creatinine. Serum protein electrophoresis shows a monoclonal IgG spike. A plain radiograph skeletal survey demonstrates multiple 'punched-out' lytic lesions in the skull and pelvis. Which of the following advanced imaging modalities is considered the most sensitive for assessing the true extent of skeletal involvement in this condition?
. Technetium-99m methylene diphosphonate (Tc-99m MDP) bone scan
. Whole-body low-dose computed tomography (WBLDCT) or MRI
. Gallium-67 citrate scan
. Dual-energy X-ray absorptiometry (DEXA)
. Indium-111 labeled white blood cell scan

Correct Answer & Explanation

. Whole-body low-dose computed tomography (WBLDCT) or MRI

Explanation

Multiple myeloma lesions are purely osteolytic and inhibit osteoblast function. Thus, a traditional Tc-99m MDP bone scan (which relies on osteoblastic activity) is frequently falsely negative. Whole-body low-dose CT (WBLDCT), whole-body MRI, or PET-CT are the modalities of choice for accurately staging and assessing skeletal involvement in multiple myeloma.

Question 1725

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with worsening knee pain. Radiographs reveal an eccentric, expansile, lytic lesion in the epiphysis of the distal femur extending to the subchondral bone. Biopsy confirms a giant cell tumor of bone. She is initiated on a systemic monoclonal antibody treatment prior to surgical intervention to consolidate the lesion. What is the primary cellular target of this medication?

. Vascular Endothelial Growth Factor (VEGF)
. Receptor Activator of Nuclear Factor Kappa-B (RANK)
. Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)
. Osteoprotegerin (OPG)
. Tyrosine Kinase Receptors

Correct Answer & Explanation

. Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)

Explanation

Denosumab is often used in the treatment of locally advanced or difficult-to-resect Giant Cell Tumors (GCT) of bone. It is a human monoclonal antibody that binds to and neutralizes RANK Ligand (RANKL). RANKL is overexpressed by the neoplastic stromal cells in GCT, which drives the recruitment and activation of the multinucleated giant cells (osteoclast-like cells) responsible for the aggressive osteolysis. By inhibiting RANKL, Denosumab halts osteoclastogenesis.

Question 1726

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of fracture healing, the local mechanical strain environment dictates the specific type of tissue that forms at the fracture site. What is the maximum tissue strain percentage that permits the formation of lamellar bone directly without an intermediate cartilaginous phase (primary bone healing)?

. Less than 2%
. Between 2% and 10%
. Between 10% and 30%
. Between 30% and 100%
. Greater than 100%

Correct Answer & Explanation

. Less than 2%

Explanation

Perren's strain theory postulates that tissues can only form if the local strain is less than the specific tissue's elongation at failure. Lamellar bone can only form and survive in environments with less than 2% strain (primary/direct bone healing). Fibrocartilage and woven bone form at moderate strains (2-10%), while granulation tissue can tolerate high strains (up to 100%).

Question 1727

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman presents with worsening right knee pain. Radiographs reveal an eccentric, lytic epiphyseal lesion of the distal femur that extends to the subchondral bone. A core biopsy confirms the diagnosis of a giant cell tumor of bone. The multidisciplinary tumor board recommends neoadjuvant treatment with denosumab prior to surgical intervention. What is the precise mechanism of action of this medication?

. Binds directly to the RANK receptor on osteoclasts
. Inhibits farnesyl pyrophosphate synthase in the mevalonate pathway
. Binds to RANKL, preventing its interaction with RANK
. Stimulates osteoprotegerin (OPG) production by osteoblasts
. Induces apoptosis of the neoplastic mononuclear cells directly

Correct Answer & Explanation

. Binds to RANKL, preventing its interaction with RANK

Explanation

Denosumab is a fully human monoclonal antibody that binds directly to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents this ligand from interacting with the RANK receptor on the surface of osteoclasts and osteoclast precursors. This prevents osteoclast formation, function, and survival, thereby halting bone resorption. In Giant Cell Tumor of Bone (GCTB), the true neoplastic cells are the mononuclear cells which secrete RANKL, driving the recruitment of reactive, destructive osteoclast-like giant cells. Denosumab targets the microenvironment signaling, not the neoplastic cells directly.

Question 1728

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with worsening knee pain. Radiographs reveal an eccentric, purely lytic lesion in the distal femoral metaphysis extending into the epiphysis up to the subchondral bone, lacking a sclerotic margin. Histology shows mononuclear stromal cells and numerous uniformly distributed multinucleated osteoclast-like giant cells. The stromal cells demonstrate a mutation in the H3F3A gene. What is the molecular target of the preferred medical therapy for unresectable disease?

. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Tyrosine kinase
. Vascular endothelial growth factor (VEGF)
. Macrophage colony-stimulating factor (M-CSF)
. Fibroblast growth factor receptor (FGFR)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)

Explanation

The diagnosis is a Giant Cell Tumor (GCT) of bone, supported by the epiphyseal/metaphyseal location, lack of sclerotic rim, characteristic histology, and H3F3A mutation. In GCT, the neoplastic mononuclear stromal cells express RANKL, which recruits and activates the reactive osteoclast-like giant cells. Denosumab, a monoclonal antibody targeting RANKL, is highly effective for locally advanced, unresectable, or recurrent GCTs.

Question 1729

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with knee pain. Radiographs reveal an eccentric, purely lytic lesion in the distal femoral epiphysis extending to the subchondral bone. Biopsy demonstrates mononuclear stromal cells interspersed with numerous multinucleated giant cells. The patient is prescribed a targeted biologic agent to reduce the tumor size prior to curettage. This agent exerts its effect by directly binding to which of the following?

. RANK receptor
. Osteoprotegerin (OPG)
. Vascular endothelial growth factor (VEGF)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Macrophage colony-stimulating factor (M-CSF)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)

Explanation

The patient has a Giant Cell Tumor (GCT) of bone, and the targeted biologic agent described is Denosumab. Denosumab is a fully human monoclonal antibody that specifically binds to RANKL. In GCT, the neoplastic mononuclear stromal cells overexpress RANKL, which recruits and stimulates the differentiation of osteoclast precursors into reactive, bone-resorbing multinucleated giant cells. By binding to and inhibiting RANKL, denosumab prevents the activation of the RANK receptor on osteoclasts, halting osteoclastogenesis and significantly reducing tumor-associated osteolysis.

Question 1730

Topic: Biology, Genetics & Bone Healing

A 68-year-old man presents with progressive bowing of his right tibia and dull, aching pain. Laboratory studies reveal an isolated elevation in serum alkaline phosphatase. Which of the following is the primary cellular defect in the early pathogenesis of this disease?

. Increased activity of structurally abnormal osteoclasts
. Defective mineralization of osteoid by osteoblasts
. Mutation in the type I collagen gene
. Defective fibroblast growth factor receptor 3 (FGFR3)
. Overproduction of parathyroid hormone-related peptide (PTHrP)

Correct Answer & Explanation

. Increased activity of structurally abnormal osteoclasts

Explanation

The patient's presentation is classic for Paget's disease of bone. The primary pathogenetic defect lies in the osteoclast. The osteoclasts are increased in number, abnormally large, and possess many more nuclei than normal osteoclasts. This leads to an initial phase of intense bone resorption, which is followed by a robust, haphazard compensatory bone formation by osteoblasts, resulting in structurally weak woven bone.

Question 1731

Topic: Biology, Genetics & Bone Healing

Which of the following statements best describes the process of intramembranous ossification during fracture healing?

. It requires a cartilaginous template prior to bone formation
. It occurs primarily through the action of chondrocytes
. It is the primary mechanism of healing in rigidly fixed fractures with absolute stability
. It depends on the influx of undifferentiated mesenchymal cells differentiating into chondroblasts
. It is clinically characterized by the formation of a prominent external fracture callus

Correct Answer & Explanation

. It is the primary mechanism of healing in rigidly fixed fractures with absolute stability

Explanation

Intramembranous ossification involves the direct differentiation of mesenchymal stem cells into osteoblasts without a cartilaginous intermediate. It is the primary mechanism of primary bone healing (contact healing) in rigidly fixed fractures (e.g., with compression plating) where strain is minimized to absolute stability. Secondary bone healing (callus formation) relies on endochondral ossification, which requires a cartilaginous template.

Question 1732

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with knee pain. Radiographs reveal an eccentric, lytic lesion in the distal femoral epiphysis extending to the subchondral bone. Biopsy confirms a giant cell tumor of bone. If medical management is initiated, denosumab works by targeting which of the following?

. RANK ligand (RANKL) expressed by the multinucleated giant cells
. RANK receptor expressed by the mononuclear stromal cells
. RANK ligand (RANKL) expressed by the mononuclear stromal cells
. Osteoprotegerin (OPG) expressed by the multinucleated giant cells
. Vascular endothelial growth factor (VEGF) expressed by the tumor cells

Correct Answer & Explanation

. RANK ligand (RANKL) expressed by the mononuclear stromal cells

Explanation

In Giant Cell Tumor (GCT) of bone, the actual neoplastic cells are the mononuclear spindle-shaped stromal cells, which express high levels of RANK ligand (RANKL). This RANKL binds to RANK receptors on the surface of normal osteoclast precursors, leading to their differentiation into reactive, bone-resorbing multinucleated giant cells. Denosumab is a monoclonal antibody that binds directly to RANKL on the stromal cells, preventing its interaction with RANK and inhibiting osteoclast-like giant cell formation.

Question 1733

Topic: Biology, Genetics & Bone Healing

A 55-year-old man undergoes an anterior lumbar interbody fusion. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is utilized to augment the fusion. What is the primary intracellular signaling pathway through which rhBMP-2 exerts its osteoinductive effect?

. Wnt/beta-catenin pathway
. Smad 1/5/8 pathway
. MAPK/ERK pathway
. JAK/STAT pathway
. Notch signaling pathway

Correct Answer & Explanation

. Smad 1/5/8 pathway

Explanation

BMPs, including rhBMP-2, bind to serine/threonine kinase receptors on the cell surface. Upon activation, they primarily signal through the phosphorylation of receptor-regulated Smad proteins (Smads 1, 5, and 8). These phosphorylated Smads form a complex with the common-partner Smad 4, which then translocates to the nucleus to regulate transcription of osteogenic target genes, including Runx2, thereby promoting osteoblast differentiation.

Question 1734

Topic: Biology, Genetics & Bone Healing

During the endochondral ossification process of fracture healing, mesenchymal stem cells differentiate into various lineages. Which transcription factor is the master regulator essential for the differentiation of these stem cells into chondrocytes?

. Runx2 (Cbfa1)
. Sox9
. Osterix (Sp7)
. Beta-catenin
. Receptor activator of nuclear factor kappa-B ligand (RANKL)

Correct Answer & Explanation

. Sox9

Explanation

Sox9 is the critical master transcription factor required for the differentiation of multipotent mesenchymal stem cells into the chondrogenic lineage during both embryonic development and endochondral fracture healing. Runx2 (Cbfa1) and Osterix (Sp7) are the essential transcription factors required for osteoblast differentiation. Beta-catenin is a key component of the Wnt signaling pathway, promoting osteoblastogenesis over chondrogenesis.

Question 1735

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman with postmenopausal osteoporosis is started on denosumab therapy to reduce her fracture risk. Which of the following best describes the molecular mechanism of action of this medication?

. It competitively binds to the RANK receptor on osteoclasts.
. It binds to RANKL, preventing the interaction between RANKL and RANK.
. It inhibits the enzyme cathepsin K, reducing bone resorption.
. It incorporates into the bone matrix and induces osteoclast apoptosis upon ingestion.
. It binds to sclerostin, increasing Wnt signaling and osteoblast activity.

Correct Answer & Explanation

. It binds to RANKL, preventing the interaction between RANKL and RANK.

Explanation

Denosumab is a fully human monoclonal antibody that binds directly to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). By binding to RANKL, it prevents RANKL from interacting with the RANK receptor on the surface of osteoclasts and their precursors. This inhibition halts osteoclast formation, function, and survival, leading to significantly decreased bone resorption. Option A is incorrect as denosumab binds the ligand (RANKL), not the receptor. Option C describes the experimental drug odanacatib. Option D describes the mechanism of bisphosphonates. Option E describes romosozumab.

Question 1736

Topic: Biology, Genetics & Bone Healing

The molecular mechanism of distraction osteogenesis relies on mechanical tension applied to healing tissue to stimulate bone formation. When the biological environment is stable and the distraction rate is optimal, which of the following types of ossification is predominantly observed?

. Endochondral ossification
. Intramembranous ossification
. Appositional ossification
. Heterotopic ossification
. Perichondral ossification

Correct Answer & Explanation

. Intramembranous ossification

Explanation

In distraction osteogenesis (Ilizarov technique), when the biological environment is mechanically stable and the distraction rate is optimal (classically 1 mm/day divided into 4 increments), the primary mechanism of bone formation is intramembranous ossification. This process involves the direct differentiation of mesenchymal stem cells into osteoblasts, laying down bone without a cartilaginous intermediate. Endochondral ossification (Option A) involves a cartilage intermediate and is typically seen in secondary fracture healing where there is relative micromotion or instability.

Question 1737

Topic: Biology, Genetics & Bone Healing

A 35-year-old woman presents with a local recurrence of a giant cell tumor of the distal femur. She is deemed a poor surgical candidate and is started on systemic therapy with a specific monoclonal antibody. What is the primary mechanism of action of this medication in the treatment of her condition?

. Inhibition of vascular endothelial growth factor (VEGF)
. Binding to RANK ligand, preventing osteoclast activation
. Inhibiting the ruffled border of osteoclasts by disrupting the actin cytoskeleton
. Inhibiting farnesyl pyrophosphate synthase
. Direct cytotoxic effect on the neoplastic mononuclear stromal cells

Correct Answer & Explanation

. Binding to RANK ligand, preventing osteoclast activation

Explanation

Denosumab is a monoclonal antibody that binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). In giant cell tumor (GCT) of bone, the neoplastic mononuclear stromal cells express RANKL, which strongly recruits and activates reactive multinucleated giant cells (osteoclast-like cells) responsible for massive osteolysis. By binding and inhibiting RANKL, denosumab halts osteoclastic bone resorption, leading to tumor calcification and disease control.

Question 1738

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction by promoting the differentiation of mesenchymal stem cells into osteoblasts. Which intracellular signaling pathway is primarily activated upon the binding of BMPs to their respective serine/threonine kinase receptors?

. Wnt/beta-catenin pathway
. MAPK/ERK pathway
. Smad pathway
. Notch signaling pathway
. PI3K/Akt pathway

Correct Answer & Explanation

. Smad pathway

Explanation

Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily. They initiate intracellular signaling by binding to type I and type II serine/threonine kinase receptors, which subsequently phosphorylate receptor-regulated Smad proteins (primarily Smad1, Smad5, and Smad8). These then form a complex with Smad4 and translocate to the nucleus to regulate the transcription of osteogenic genes.

Question 1739

Topic: Biology, Genetics & Bone Healing

A 45-year-old woman with a history of end-stage renal disease presents with diffuse, dull bone pain and proximal muscle weakness. Laboratory studies show hypocalcemia, hyperphosphatemia, and elevated intact parathyroid hormone (PTH) levels. Radiographs demonstrate focal radiolucencies traversing the femoral necks bilaterally. The primary histologic defect in this patient's skeletal pathology is characterized by:

. Defective mineralization of osteoid
. Excessive osteoclastic bone resorption
. Defective synthesis of type I collagen
. Overproduction of woven bone without lamellar remodeling
. Decreased primary formation of osteoid by osteoblasts

Correct Answer & Explanation

. Defective mineralization of osteoid

Explanation

The patient is presenting with signs of osteomalacia secondary to renal osteodystrophy (caused by decreased 1,25-dihydroxyvitamin D production and consequent hypocalcemia). The focal radiolucencies are Looser zones (pseudofractures). The fundamental histologic hallmark of osteomalacia (and rickets in children) is an accumulation of unmineralized osteoid seams due to defective mineralization of newly formed bone matrix.

Question 1740

Topic: Biology, Genetics & Bone Healing

An 8-year-old boy presents with severe limb pain, bleeding gums, and extensive petechiae. Radiographs of the lower extremities reveal generalized osteopenia with a characteristic dense provisional zone of calcification at the metaphyses. The underlying biochemical defect responsible for this clinical presentation involves the failure of which specific process?

. Carboxylation of osteocalcin
. Hydroxylation of proline and lysine residues
. Cleavage of procollagen to tropocollagen
. Cross-linking of tropocollagen molecules by lysyl oxidase
. Glycosylation of hydroxylysine residues

Correct Answer & Explanation

. Hydroxylation of proline and lysine residues

Explanation

The presentation is classic for scurvy (Vitamin C deficiency). Ascorbic acid is an essential cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which mediate the hydroxylation of proline and lysine residues on nascent procollagen chains. This hydroxylation is critical for stabilizing the collagen triple helix via hydrogen bonding. A deficiency leads to fragile connective tissues, weakened blood vessels (bleeding), and defective bone matrix synthesis.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page